Risk stratification for discontinuation of P2Y12 receptor antagonists clopidogrel, prasugrel or ticagrelor based on the risk of thrombosis
| High risk of thrombosis | Low risk of thrombosis |
| Drug eluting coronary artery stents within 12 months of placement | Ischaemic heart disease without coronary stents |
| Bare metal coronary artery stents within 1 month of placement | Cerebrovascular disease |
| Peripheral vascular disease |